Dr7.ai

Dr7.ai is a unified API gateway and web platform that centralizes access to more than 15 specialized medical AI models under a single integration point. Rather than building separate connections to each model provider, developers and healthcare teams can authenticate once and route requests to whichever model fits their clinical task — whether that is radiology interpretation, EHR extraction, genomic analysis, or medical Q&A.

What It Does

The platform aggregates a curated set of healthcare-focused language and multimodal models, including MedGemma, Med-PaLM, BioGPT, LLaVA-Med, CheXagent, Meditron, PMC-LLaMA, Baichuan-M3, and AlphaGenome, among others. Each model is categorized by domain — imaging, NLP, drug discovery, clinical dialogue — so teams can identify the right tool without evaluating the broader AI landscape from scratch.

Beyond raw API access, Dr7.ai includes a built-in AI diagnosis interface aimed at clinicians who want to run patient case data through medical LLMs without writing code. The platform also offers side-by-side performance benchmarking, letting users compare models by speed, accuracy, and cost before committing to one for a production workflow.

Who It Is For

The primary audience is healthcare developers and health-tech teams building products on top of medical AI. Integrating a single API instead of managing multiple provider relationships reduces onboarding overhead significantly, which matters when a product needs to support several clinical use cases simultaneously.

Clinicians and hospital IT teams are a secondary audience. The AI diagnosis interface lowers the technical barrier for non-developers, while the platform's stated HIPAA and GDPR compliance posture makes it easier for institutional buyers to begin an evaluation. Medical researchers comparing model performance across tasks — USMLE benchmarks, radiology accuracy, biomedical NLP — also have a clear use case here.

Typical Workflows

A common pattern is using MedGemma or Med-PaLM to extract structured data from unstructured EHR notes, feeding that output into a clinical decision-support layer. Radiology teams can route X-ray or CT images through CheXagent or LLaVA-Med for automated annotation and triage flagging. Drug discovery pipelines can call biomedical models for molecular interaction screening without standing up separate infrastructure.

For teams building patient-facing products, the multilingual support across models enables deployment in international markets without rebuilding the AI layer per language. The sub-100ms response time claim and 99.9% uptime target position the platform for production workloads rather than just prototyping.

Important Limitations

Dr7.ai is explicit that its models are not clinical-grade tools. The platform is intended for research, development, and informational use. Any deployment in actual patient care requires independent validation, regulatory approval, and oversight by qualified healthcare professionals. Organizations handling real patient data should review the platform's BAA terms and conduct their own compliance due diligence before going live.

Because Dr7.ai aggregates third-party models rather than developing them in-house, output quality is ultimately tied to the upstream providers. There is also no visible on-premise or self-hosted deployment path for teams with strict data residency requirements.

Pricing and Access

Dr7.ai operates on a freemium model. A free trial is available with no credit card required, giving developers immediate access to test the API and evaluate model outputs before committing to a paid plan. A Pro plan is available for medical professionals and teams with higher usage needs. Full pricing details are on a separate page rather than surfaced on the homepage, so prospective users will need to check current tier limits directly.